Austin Health

Title
The Relationship between Residual Kidney Function and Symptom Burden in Hemodialysis Patients.
Publication Date
2020-02-11
Author(s)
Kong, Jessica H
Davies, Matthew R P
Mount, Peter F
Subject
hemodialysis
potassium
residual kidney function
uremic symptoms
β2-microglobulin
Type of document
Journal Article
OrcId
0000-0001-7637-3661
0000-0001-8780-034X
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1111/imj.14775
Abstract
Residual kidney function (RKF) has been associated with improved solute clearance and survival in hemodialysis (HD) patients. However, whether RKF impacts symptom burden in HD patients is unknown. To determine the prevalence of RKF in HD patients and to explore associations between higher levels of RKF with symptom burden, as well as clinical and biochemical parameters. This is a single centre, retrospective, observational study. RKF was assessed as urea clearance (KRU) by interdialytic urine collection. Symptom burden was measured using the palliative care outcome scale renal questionnaire. 90 maintenance HD patients were recruited. 31.9% had KRU ≥1ml/min/1.73m2. Patients with KRU ≥1ml/min/1.73m2 reported fewer symptoms (5.3 ± 3.5 vs 7.7 ± 3.8) (p=0.011), including less shortness of breath (15% vs 55%) (p=0.0013) and vomiting (0% vs 30%) (p=0.0016). Higher RKF was associated with lower β2-microglobilin (p<0.0001), and lower serum potassium (p=0.02), but no difference in phosphate, hemoglobin, C-reactive protein or serum albumin. Higher RKF was significantly associated with fewer symptoms, and lower serum β2-microglobilin and potassium, suggesting that strategies to preserve RKF may be beneficial. This article is protected by copyright. All rights reserved.
Link
Citation
Internal Medicine Journal 2020; online first: 11 February
Jornal Title
Internal Medicine Journal

Files:

NameSizeformatDescriptionLink